Welcome to LookChem.com Sign In|Join Free
  • or
3-Isoxazolamine,5-(1,1-dimethylethyl)-N-methyl-(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

55809-35-3

Post Buying Request

55809-35-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55809-35-3 Usage

State

stable solid at room temperature

Solubility

soluble in various organic solvents
Derivative of isoxazolamine
Used in the synthesis of other organic compounds
Potential applications in pharmaceutical or agrochemical research
Properties and uses may vary depending on intended application and formulation

Check Digit Verification of cas no

The CAS Registry Mumber 55809-35-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,8,0 and 9 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 55809-35:
(7*5)+(6*5)+(5*8)+(4*0)+(3*9)+(2*3)+(1*5)=143
143 % 10 = 3
So 55809-35-3 is a valid CAS Registry Number.

55809-35-3Downstream Products

55809-35-3Relevant academic research and scientific papers

Herbicidal Compounds

-

Paragraph 0281; 0282, (2016/10/17)

The invention relates to pyrrolone compounds of the formula (I) wherein X, Rb, Rc, R1, R2 and R3 are as defined in the specification. Furthermore, the present invention relates to processes and intermediates for making compounds of formula (I), to herbicidal compositions comprising these compounds and to methods of using these compounds to control plant growth.

PYRIMIDINES WITH TIE2 (TEK) ACTIVITY

-

Page/Page column 125, (2010/02/12)

The invention relates to a compound of the Formula (I). or salt thereof wherein R1, R2, R3, R4, R5, R6, A, B, L, n and m are as defined in the description. The invention also relates to pharmaceutical compositions of said compounds, the use of said compounds as medicaments and in the production of an anti-angiogenic effect in a warm-blooded animal. The invention also relates to processes for the preparation of said compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 55809-35-3